investigated the role of the deubiquitination enzyme activity of CYLD in colitis -associated colorectal cancer using a conditioned CYLD inactivation mouse model (IEC-CYLDΔ9 mice, which harbors a mutation that eliminated the CYLD deubiquitination domain in IECs) (136). The gene discussed is CYLD; the disease is colitis.